Oncology Institute, Inc. TOI
Nasdaq · XNAS · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2020-03-13
Chart by TradingView
4/9
Piotroski F — financial health
-5.27
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $502.7M | $393.4M | $324.2M | $252.5M | $203.0M |
| Operating income | -$36.1M | -$60.1M | -$77.0M | -$82.0M | -$45.9M |
| Net income | -$60.6M | -$64.7M | -$83.1M | $152,000 | -$10.9M |
| Operating cash flow | -$24.6M | -$26.5M | -$36.3M | -$61.8M | -$32.7M |
| Free cash flow | -$27.8M | -$30.3M | -$40.9M | -$67.3M | -$35.5M |
| Total assets | $164.7M | $172.7M | $209.2M | $261.7M | $203.4M |
| Total liabilities | $180.4M | $169.1M | $152.2M | $138.5M | $99.3M |
| Shareholders' equity | -$15.7M | $3.6M | $57.0M | $123.2M | $104.2M |
| Ratios | |||||
| Operating margin | -7.2% | -15.3% | -23.8% | -32.5% | -22.6% |
| Net margin | -12.1% | -16.4% | -25.6% | 0.1% | -5.4% |
| FCF margin | -5.5% | -7.7% | -12.6% | -26.6% | -17.5% |
| Return on assets | -36.8% | -37.4% | -39.7% | 0.1% | -5.4% |
| Return on equity | 385.5% | -1801.7% | -145.7% | 0.1% | -10.5% |
| Debt / equity | -4.92× | 25.95× | 1.52× | 0.65× | 0.00× |
| Current ratio | 1.59 | 2.15 | 4.12 | 4.39 | 5.17 |
| Revenue growth | 27.8% | 21.3% | 28.4% | 24.4% | 8.3% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 902,809 | $2.8M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -5.27 (distress)
- Working capital / assets 0.254
- Retained earnings / assets -1.648
- EBIT / assets -0.219
- Equity / liabilities -0.087
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001799191 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.